Literature DB >> 7050257

Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.

M G Bergeron, S Trottier, C Lessard, D Beauchamp, P M Gagnon.   

Abstract

The intracortical, medullary, and papillary distribution of gentamicin was studied in normal and pyelonephritic rats. The animals were evaluated from 1 hr to 365 days after the end of therapy with either a single dose or two daily injections given every 12 hr for seven days. The serum levels of gentamicin at 1 hr were significantly (P less than 0.001) higher in the pyelonephritic rats than in the normal rats after one dose (26 vs. 12 microgram/ml) and 14 doses (25.7 vs. 8.8 microgram/ml). Peak concentrations or gentamicin in all parts of infected kidneys were significantly (P less than 0.001) higher than in normal kidneys. Gentamicin was still detectable at levels of 1.2 microgram/g in the cortex of one pyelonephritic animal one year after the end of therapy, when the levels of both serum creatinine (1.1 mg/100 ml) and blood urea nitrogen (30 mg/100 ml) were much higher than at seven days after the end of therapy (0.5 and 19 mg/100 ml, respectively).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050257     DOI: 10.1093/infdis/146.3.436

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Intrarenal distribution of vancomycin in endotoxemic rats.

Authors:  M Ngeleka; P Auclair; D Tardif; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 3.  Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage.

Authors:  C Carbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

4.  Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin.

Authors:  M G Bergeron; Y Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

5.  Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.

Authors:  P R Meylan; G Braoudakis; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  Autoradiography of tobramycin uptake by the proximal and distal tubules of normal and endotoxin-treated rats.

Authors:  M G Bergeron; Y Bergeron; Y Marois
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

7.  Prolonged endotoxemia enhances the renal injuries induced by gentamicin in rats.

Authors:  P Auclair; D Tardif; D Beauchamp; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

8.  Alterations in pharmacokinetics and protein binding behavior of cefazolin in endotoxemic rats.

Authors:  M Nadai; T Hasegawa; K Kato; L Wang; T Nabeshima; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.

Authors:  M Tardif; D Beauchamp; Y Bergeron; C Lessard; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

10.  Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.

Authors:  P Auclair; C Lessard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.